Literature DB >> 7895545

Glycine-to-arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier.

K Hino1, M Okuda, O Hashimoto, H Ishiko, M Okazaki, K Fujii, H Hanada, K Okita.   

Abstract

Two daughters born to an HBeAg-positive carrier became hepatitis B virus carriers despite immunoprophylaxis with hepatitis B immune globulin or hepatitis B vaccine. The elder daughter received hepatitis B immune globulin alone and the younger daughter received both hepatitis B immune globulin and hepatitis B vaccine. They acquired anti-HBs passively immediately after birth, and the younger daughter did not respond to active immunization. The nucleotide sequence of the S gene of hepatitis B virus DNA from the four carriers in the family was determined. A 531-bp fragment within the S gene, which includes a region encoding both the common a and type-specific d/y or r/w determinants, was amplified by polymerase chain reaction and sequenced. Antigenic subtypes of HBV were identified as adr in the father and adw in both the mother and two daughters. Amino acid residues 122-160 of HBsAg were identical between the daughters and their mother except for a glycine-to-arginine substitution at codon 145. A possibility that this escape mutant had selective advantage over wild-type hepatitis B virus under immune pressure is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7895545     DOI: 10.1007/bf02064370

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Independent emergence of a vaccine-induced escape mutant of hepatitis B virus.

Authors:  T J Harrison; E A Hopes; C J Oon; A R Zanetti; A J Zuckerman
Journal:  J Hepatol       Date:  1991       Impact factor: 25.083

2.  Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients.

Authors:  G McMahon; P H Ehrlich; Z A Moustafa; L A McCarthy; D Dottavio; M D Tolpin; P I Nadler; L Ostberg
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

3.  Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes.

Authors:  H Okamoto; M Imai; M Shimozaki; Y Hoshi; H Iizuka; T Gotanda; F Tsuda; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1986-11       Impact factor: 3.891

4.  Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus.

Authors:  H Fujii; K Moriyama; N Sakamoto; T Kondo; K Yasuda; Y Hiraizumi; M Yamazaki; Y Sakaki; K Okochi; E Nakajima
Journal:  Biochem Biophys Res Commun       Date:  1992-05-15       Impact factor: 3.575

5.  Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.

Authors:  R P Beasley; L Y Hwang; G C Lee; C C Lan; C H Roan; F Y Huang; C L Chen
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

6.  Precore mutant hepatitis B virus infection and liver disease.

Authors:  N V Naoumov; R Schneider; T Grötzinger; M C Jung; S Miska; G R Pape; H Will
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

9.  Prevention of perinatal transmission of the hepatitis B virus. Outcome of infants in a community prevention program.

Authors:  M T Niu; P V Targonski; B J Stoll; G P Albert; H S Margolis
Journal:  Am J Dis Child       Date:  1992-07

10.  The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw.

Authors:  Y Ono; H Onda; R Sasada; K Igarashi; Y Sugino; K Nishioka
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

View more
  7 in total

1.  Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.

Authors:  Julie van Schalkwyk; Melica Nourmoussavi; Andrea Massey; Reka Gustafson; Elizabeth Brodkin; Martin Petric; Mel Krajden; Simon Dobson; Jane Buxton; Mark Bigham; Neora Pick; Rick Schreiber; Christopher H Sherlock; Deborah Money; Eric M Yoshida
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

2.  Use of PCR in resolving diagnostic difficulties potentially caused by genetic variation of hepatitis B virus.

Authors:  F J van Deursen; K Hino; D Wyatt; P Molyneaux; P Yates; L A Wallace; B C Dow; W F Carman
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

3.  Hepatitis B virus S gene escape mutants.

Authors:  Michael A Purdy
Journal:  Asian J Transfus Sci       Date:  2007-07

4.  Hepatitis B surface gene 145 mutant as a minor population in hepatitis B virus carriers.

Authors:  Haruki Komatsu; Ayano Inui; Tsuyoshi Sogo; Yasuhiro Konishi; Akihiko Tateno; Tomoo Fujisawa
Journal:  BMC Res Notes       Date:  2012-01-10

5.  Subgenotypes and mutations in the s and polymerase genes of hepatitis B virus carriers in the West Bank, palestine.

Authors:  Zakeih Abdelnabi; Niveen Saleh; Sabri Baraghithi; Dieter Glebe; Maysa Azzeh
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

6.  Evaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child Transmission.

Authors:  Haruki Komatsu; Ayano Inui; Shuichiro Umetsu; Tomoyuki Tsunoda; Tsuyoshi Sogo; Yasuhiro Konishi; Tomoo Fujisawa
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

7.  Deep sequencing of hepatitis B surface antigen gene in the preserved umbilical cords in immunoprophylaxis failure against mother-to-child HBV transmission.

Authors:  Haruki Komatsu; Ayano Inui; Yasuto Suzuki; Masaya Sugiyama; Tomoo Fujisawa
Journal:  BMC Infect Dis       Date:  2019-11-21       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.